Detalhe da pesquisa
1.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Lancet
; 398(10318): 2258-2276, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34863358
2.
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre.
Transfus Med
; 32(3): 256-260, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474619
3.
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.
Lancet Infect Dis
; 23(5): 589-597, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566771
4.
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
J Infect
; 84(6): 795-813, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405168
5.
A case of progressive breathlessness post partum.
Thorax
; 71(9): 871-2, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27369355
6.
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice.
J Antimicrob Chemother
; 66(8): 1815-20, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21642291
7.
Case of eosinophilic fasciitis during military training in a Nepalese British infantry soldier.
BMJ Mil Health
; 166(4): 277-278, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32139410
8.
Centralising human resources paperwork would improve rotational training.
BMJ
; 384: q746, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531594
9.
Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].
J Infect
; 86(5): 540-541, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055303